Capital and Operating Cost Evaluation of CAS vs. MBR Treatment
This study details the development and refinement of an Excel® based tool to compare the capital and operating cost of equivalent size greenfield wastewater treatment facilities using membrane bioreactors (MBR) and conventional activated sludge (CAS) based on identical influent loading conditions, variable temperature and flow peaking factors, and varying levels of effluent treatment objectives. The resulting capital and operating cost tables developed using this tool indicate which system is most cost-effective for each scenario evaluated. The tool can also be used to easily compare the 20-year Present Worth cost impacts of changing input variables such as the cost of concrete, land, chemicals, or electricity.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
Document Type: Research Article
Publication date: 2012-01-01
WEF Members: Sign in (right panel) with your IngentaConnect user name and password to receive complimentary access. Access begins 12 months after the conference or event
- Subscribe to this Title
- Membership Information
- About WEF Proceedings
- WEFTEC Conference Information
- Learn about the many other WEF member benefits and join today
- Ingenta Connect is not responsible for the content or availability of external websites